Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (161-170 of 551) with videos related to

Pageof 56
Sort By:
The Journal of Clinical Investigation|July 1, 1988
HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphomaT P Miller, S M Lippman, C M Spier, et al.
Head & Neck Oncology|July 1, 2010
Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)Farshid Dayyani, Carol J Etzel, Mei Liu, et al.
Investigational New Drugs|January 1, 1995
Phase II study of cisplatin, 5-fluorouracil and interferon-alpha in recurrent carcinoma of the cervixC Gonzales-de Léon, S M Lippman, A P Kudelka, et al.
American Journal of Physical Medicine & Rehabilitation|July 31, 2019
A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors After Curative-Intent TreatmentDuc Ha, Jacqueline Kerr, Andrew L Ries, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 15, 2006
The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancerImad Shureiqi, Xiangsheng Zuo, Russell Broaddus, et al.
The Cancer Journal From Scientific American|March 1, 1997
Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experienceV A Papadimitrakopoulou, I W Dimery, J J Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breastAshraful Hoque, Jennifer Carter, Weiya Xia, et al.
British Journal of Cancer|March 1, 2002
Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapyI Shureiqi, S B Cantor, S M Lippman, et al.
Carcinogenesis|April 28, 2006
Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesionsMaosheng Huang, Margaret R Spitz, Jian Gu, et al.
Scientific Reports|July 15, 2018
Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer PatientsJeanne A Pierzynski, Yuanqing Ye, Scott M Lippman, et al.
Pageof 56

Showing results (161-170 of 551) with videos related to

Sort By:
Pageof 56
The Journal of Clinical Investigation|July 1, 1988
HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphomaT P Miller, S M Lippman, C M Spier, et al.
Head & Neck Oncology|July 1, 2010
Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)Farshid Dayyani, Carol J Etzel, Mei Liu, et al.
Investigational New Drugs|January 1, 1995
Phase II study of cisplatin, 5-fluorouracil and interferon-alpha in recurrent carcinoma of the cervixC Gonzales-de Léon, S M Lippman, A P Kudelka, et al.
American Journal of Physical Medicine & Rehabilitation|July 31, 2019
A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors After Curative-Intent TreatmentDuc Ha, Jacqueline Kerr, Andrew L Ries, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 15, 2006
The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancerImad Shureiqi, Xiangsheng Zuo, Russell Broaddus, et al.
The Cancer Journal From Scientific American|March 1, 1997
Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experienceV A Papadimitrakopoulou, I W Dimery, J J Lee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 25, 2003
Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breastAshraful Hoque, Jennifer Carter, Weiya Xia, et al.
British Journal of Cancer|March 1, 2002
Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapyI Shureiqi, S B Cantor, S M Lippman, et al.
Carcinogenesis|April 28, 2006
Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesionsMaosheng Huang, Margaret R Spitz, Jian Gu, et al.
Scientific Reports|July 15, 2018
Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer PatientsJeanne A Pierzynski, Yuanqing Ye, Scott M Lippman, et al.
Pageof 56